Watchlist

Watchlist
Aevi Genomic Medicine, Inc. (GNMX)
Aevi Genomic Medicine, Inc. (GNMX)
ROTY Edition 1 Volume 58: Increasing Contender Coverage And Trades
Welcome to the 58th entry in our Runner of the Year ((ROTY)) series. Our model account utilizes a full-position size of $10,000 and can hold up to 10 positions. Trades typically occur in quarter increments ($2,500) with cost averages calculated at the day's close. The model account is primar…
Aevi Genomic Medicine Announces New Appointment to its Board of Directors
PHILADELPHIA , Dec. 4, 2017 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) announced today the appointment of Matthew D. Bayley , MD, MBA to its Board of Directors. "We are excited to welcome Matt to our Board of Directors during this important time for the…
Aevi Genomic Medicine: Several Catalysts Coming In The Middle Of 2018
Shares of Aevi Genomic Medicine (GNMX) rose by as much as 35% since my latest update piece towards the end of August. The stock has now swung completely around and is currently in the red by 11%. GNMX data by YCharts While pops in stock prices due solely to insider buying rarely last…
A Current Look At The ROTY Contenders List
ROTY (Runners of the Year) is a strategy which involves two parts, the official 10 stock model account and our Contenders List of ideas. Basically, we are looking for stocks that could outperform (ideally double or more) within the near to medium term (next quarter to 12 months out). While the…
Aevi Genomic Medicine Reports Third Quarter 2017 Financial Results
PHILADELPHIA , Nov. 2, 2017 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) announced today financial and operational results for the quarter ended September 30, 2017 and provided a corporate update. Third Quarter and Recent Corporate Highlights I…
Can Pharma Succeed In A Condition Impacting 1 In 68 Children?
About Autism In 2014, the CDC estimated that 1 in 68 children in the United States have a neurodevelopmental condition known as Autism Spectrum Disorder (or Autism). This included 1 in 42 boys (versus 1 in 189 girls). Of note, there is some regional variation, with New Jersey having a rate…
Midday Gainers / Losers
Gainers: SKX +37% . QURE +23% . TEAM +22% . DGLY +20% . TUSK +18% . DRYS +17% . CAI +16% . XNET +14% . KALV +12% . JP +12% . More news on: Skechers USA Inc., uniQure N.V., Atlassian, Stocks on the move, Read more …
ROTY Volume 1 Edition 41: Adding Selectively On Weakness
Welcome to the 41st entry in our Runner of the Year (ROTY) series. Our model account utilizes a full-position size of $10,000 and can hold up to 10 positions. Trades typically occur in quarter increments ($2,500), with cost averages calculated at the day's close. The model account is primari…
Daily Insider Ratings Round Up 10/18/17: GNMX, SKY, AXDX, CONN, PWON, SXCP, CCUR
InsiderInsights' Daily Round Up articles rate the "significance" of the top 10 dollar value insider purchases and sales filed at the SEC on the Title date. Dollar value is only the most basic metric to assess the significance of an insider transaction, however, and there are many more "Signifi…
Midday Gainers / Losers
Gainers: IMMY +47% . QURE +47% . ADHD +35% . GNMX +28% . PRAN +20% . RWLK +16% . SILC +16% . ZDGE +13% . CIDM +14% . RGSE +14% . More news on: Imprimis Pharmaceuticals, Inc., uniQure N.V., Alcobra Ltd., Stocks on the move, Read more …
Aevi perks up 13% on insider activity
Thinly traded nano cap Aevi Genomic Medicine ( GNMX +12.5% ) jumps on a 9x surge in volume in apparent response to Form 4 filings after the close yesterday disclosing stock purchases by insiders. More news on: Aevi Genomic Medicine, Inc., Healthcare stocks news, Stocks on the move, R…
Aevi Genomic Medicine, Inc. (GNMX)